Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.

2019 ; Vol.29-9: 1335~1340

AuthorSeon-Kyun Kim, Robin B. Guevarra, You-Tae Kim, Joongi Kwon, Hyeri Kim, Jae Hyoung Cho, Hyeun Bum Kim, Ju-Hoon Lee
Place of dutyDepartment of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea
TitleRole of Probiotics in Human Gut Microbiome-Associated Diseases
PublicationInfo J. Microbiol. Biotechnol.2019 ; Vol.29-9
AbstractProbiotics, including bacteria and yeast, are live microorganisms that have demonstrated beneficial effects on human health. Recently, probiotic bacteria are constantly being studied and their applications are also being considered in promising adjuvant treatments for various intestinal diseases. Clinical trials and in vivo experiments have extended our current understanding of the important roles that probiotics play in human gut microbiomeassociated diseases. It has been documented through many clinical trials that probiotics could shape the intestinal microbiota leading to potential control of multiple bowel diseases and promotion of overall wellness. In this review, we focused on the relationship between probiotics and the human gut microbiota and its roles in gut microbiome-associated diseases. Here, we also discuss future directions and research areas that need further elucidation in order to better understand the roles of probiotics in the treatment of intestinal diseases.
Full-Text
Key_wordHuman gut microbiota, intestinal disease, probiotics
References
  1. de Simone C. 2018. The unregulated probiotic market. Clin. Gastroenterol. H. 17: 809-817
    Pubmed CrossRef
  2. Choi S, Hwang Y-J, Shin M-J, Yi H. 2017. Difference in the gut microbiome between Ovariectomy-induced obesity and diet-induced obesity. J. Microbiol. Biotechnol. 27: 2228-2236.
    Pubmed CrossRef
  3. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
    Pubmed CrossRef Pubmed Central
  4. Wang W, Xing W, Wei S, Gao Q, Wei X, Shi L, et al. 2018. Semi-rational screening of the probiotics from the fecal flora of healthy adults against DSS-induced colitis mice by enhancing anti-inflammatory activity and modulating the gut microbiota. J. Microbiol. Biotechnol. [Epub ahead of print]
  5. Sanders ME, Heimbach JT, Pot B, Tancredi DJ, LenoirWijnkoop I, Lähteenmäki-Uutela A, et al. 2 011. H ealth claims substantiation for probiotic and prebiotic products. Gut Microbes 2: 127-133.
    Pubmed CrossRef
  6. Lorea Baroja M, Kirjavainen P, Hekmat S, Reid G. 2007. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149: 470-479.
    Pubmed CrossRef Pubmed Central
  7. Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, et al. 2002. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 16: 1461-1467.
    Pubmed CrossRef
  8. Bae J-Y, Kim JI, Park S, Yoo K, Kim I-H, Joo W, et al. 2018. Effects of Lactobacillus plantarum and Leuconostoc mesenteroides Probiotics on Human Seasonal and Avian Influenza Viruses. J. Microbiol. Biotechnol. 28: 893-901.
    Pubmed CrossRef
  9. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-1270.
    Pubmed CrossRef Pubmed Central
  10. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
    Pubmed CrossRef
  11. Flint H J, S cott K P, D uncan SH, Louis P, F orano E. 2 012. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3: 289-306.
    Pubmed CrossRef Pubmed Central
  12. Apajalahti J. 2005. Comparative gut microflora, metabolic challenges, and potential opportunities. J. Appl. Poultry Res.14: 444-453.
    CrossRef
  13. Wen H, Yin X, Yuan Z, Wang X, Su S. 2018. Comparative Analysis of Gut Microbial Communities in Children under 5 Years Old with Diarrhea. J. Microbiol. Biotechnol. 28: 652-662.
  14. Marteau P, Seksik P, Jian R. 2002. Probiotics and intestinal health effects: a clinical perspective. Br. J. Nutr. 88: S51-S57.
    Pubmed CrossRef
  15. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. 2010. Disordered microbial communities in asthmatic airways. PLoS One 5(1): e8578.
    Pubmed CrossRef Pubmed Central
  16. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. 2015. Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis. 26: 26191.
    Pubmed CrossRef Pubmed Central
  17. Ouwehand A, Kirjavainen P, Grönlund M-M, Isolauri E, Salminen S. 1999. Adhesion of probiotic micro-organisms to intestinal mucus. Int. Dairy J. 9: 623-630.
    CrossRef
  18. Blaabjerg S, Artzi DM, Aabenhus R. 2017. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in OutpatientsA Systematic Review and Meta-Analysis. Antibiotics. 6(4).pii: E21.
    Pubmed CrossRef Pubmed Central
  19. Conway S, Hart A, Clark A, Harvey I. 2007. Does eating yogurt prevent antibiotic-associated diarrhoea?: A placebocontrolled randomised controlled trial in general practice. Br. J. Gen. Pract. 57: 953-959.
    Pubmed CrossRef Pubmed Central
  20. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. 1999. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr. 135:564-568.
    CrossRef
  21. Bjarnason I, Sission G, Hayee B. 2019. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. Inflammopharmacology 27: 465-473.
    Pubmed CrossRef Pubmed Central
  22. Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. 2015. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J. Gastroenterol. 65: 215-221.
    Pubmed CrossRef
  23. Yang J, Yu J. 2018. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell 9: 474-487.
    Pubmed CrossRef Pubmed Central
  24. Furrie E, Macfarlane S, Kennedy A, Cummings J, Walsh S, O’Neil D, et al. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54: 242-249.
    Pubmed CrossRef Pubmed Central
  25. Baumgart DC, Carding SR. 2007. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
    CrossRef
  26. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. 2010. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 65: 384-390.
    Pubmed CrossRef
  27. Fedorak RN, Feagan BG, Hotte N, Leddin D, Dieleman LA, Petrunia DM, et al. 2015. The probiotic VSL#3 has antiinflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clin. Gastroenterol. Hepatol. 13: 928-935.
    Pubmed CrossRef
  28. Center MM, Jemal A, Smith RA, Ward E. 2009. Worldwide variations in colorectal cancer. CA Cancer J. Clin. 59: 366-378.
    Pubmed CrossRef
  29. Triantafillidis JK, Nasioulas G, Kosmidis PA. 2009. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29: 2727-2737.
  30. Liong M-T. 2008. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 9: 854-863.
    Pubmed CrossRef Pubmed Central
  31. Krebs B. 2016. Prebiotic and Synbiotic treatment before colorectal surgery-randomised double blind trial. Coll. Antropol. 40: 35-40.
  32. Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. 2006. Probiotic use in clinical practice: what are the risks?. Am. J. Clin. Nutr. 83: 1256-1264.
    Pubmed CrossRef
  33. Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, et al. 2003. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig. Dis. Sci. 48:2077-2082.
    Pubmed CrossRef
  34. Yang Y, Xia Y, Chen H, Hong L, Feng J, Yang J, et al. 2016. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget 7: 8432-8440.
    CrossRef



Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang Co., Ltd